Meyka Pro banner
Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. (TMO) Stock Overview

Explore Thermo Fisher Scientific Inc.’s financial performance, market position, analyst ratings, and future outlook.

TMONYSE
HealthcareMedical - Diagnostics & Research
$627.55
$14.010(2.28%)
U.S. Market opens in 1h 26m

Thermo Fisher Scientific Inc. (TMO)

Meyka AI Score

Z

Key Financials

Market Cap233.2B
P/E Ratio33.73
EPS (TTM)$23.16
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$581.69
3 Months$610.87
1 Year Target$534.81

TMO Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Thermo Fisher Scientific Inc. (NYSE: TMO) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Thermo Fisher Scientific Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TMO on the NYSE shows an RSI of 74.40, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $534.81 for the NYSE listing.

Key metrics behind Thermo Fisher Scientific Inc.'s NYSE-traded stock include a P/E ratio of 33.73 and a market capitalization of 233.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of TMO on the NYSE.

Price Performance (NYSE: TMO)

1-Day Change
2.30%
5-Day Change
6.00%
1-Month Change
19.27%
3-Month Change
38.92%
6-Month Change
22.84%
Year-to-Date (YTD) Change
8.32%
1-Year Change
26.84%
3-Year Change
17.92%
5-Year Change
13.09%
All-Time (Max) Change
49712.30%

Contact Information

781 622 1000
168 Third Avenue, Waltham, MA, 02451

Company Facts

1,250,000 Employees
IPO DateMar 17, 1980
CountryUS
Actively Trading

Frequently Asked Questions